UNSPSC 51283909: Sulfadimethoxine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C12H14N4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 30CPC5LDEX, chemically known as 2,6-dimethoxy-4-sulfanilamidopyrimidine but generally known as sulfadimethoxine, which bears US NIH Compound Identifier 5323. European Medicines Agency schedules Sulfadimethoxine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10698MIG.

UNSPSC 51283909 Sulfadimethoxine is a Commodity code for a specific veterinary or animal-health pharmaceutical product, but recent state and local procurement activity tagged with this code does not reflect purchases of sulfadimethoxine itself. Instead, the opportunities solicited under the code span emergency medical supplies, naloxone and drug deactivation systems, direct-to-manufacturer pharmaceutical procurement models, and generic multi-source pharmaceuticals and over-the-counter products distributed through cooperative purchasing arrangements. The mismatch between the code's nominal scope and what is actually being bought suggests the code sees limited direct activity for its named product, or that tagging inconsistencies have classified unrelated pharmaceutical and health-supply purchases under it.

Recent opportunities span multiple issuing-body types: county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and cooperative purchasing alliances serving multi-state and multi-jurisdictional membership (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The geographic footprint includes Florida, Texas, and Minnesota with broader participation in MMCAP jurisdictions including Oregon. Representative recent opportunities include Seminole County's IFB 60459723LAS seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually (response due July 26, 2023); the City of Tampa's IFB 26-P-00145 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000.00 and a small local business enterprise set-aside (response due March 13, 2026); Texas HHS Commission's RFI HHS0017013 exploring direct-to-manufacturer prescription programs (response due April 3, 2026); and MMCAP's RFP S1070000015802 establishing multi-vendor contracts for generic pharmaceuticals and OTC products across state and local facilities (response due March 26, 2026). The code shows little relevant recent activity for its stated pharmaceutical product and warrants verification before pursuit.